T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Crossref DOI link: https://doi.org/10.1007/s13238-016-0367-1
Published Online: 2017-01-20
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ping, Yu
Liu, Chaojun
Zhang, Yi http://orcid.org/0000-0001-9861-4681
License valid from 2017-01-20